The FDA has classified a correction to Insulet's Omnipod systems as a Class I recall due to a cannula defect. This recall impacts all three generations of the company's pod-based systems, including the Omnipod 5, Omnipod DASH, and the original Omnipod (Eros). The company has faced previous issues, with serious injuries tied to Omnipod patches and a prior recall over a tubing tear.

Skyworks Solutions is a global semiconductor company specializing in analog and mixed-signal solutions for wireless connectivity, with its business model centered on long-term demand for data, mobility, and the Internet of Things. The company designs integrated circuits to manage radio frequency signals and power across various applications like smartphones, smart home devices, and industrial sensors. Skyworks Solutions trades on a major U.S. exchange, and its performance is influenced by wireless data usage growth, device unit volumes, and strategic diversification beyond handsets into infrastructure and other emerging markets.

CDW Corp. is a leading technology solutions provider specializing in hardware, software, and IT services for business, government, and education clients. The company acts as a value-added reseller and solutions provider, offering comprehensive support from consulting and configuration to deployment and ongoing management of IT infrastructure. By focusing on solution design, lifecycle services, and strong vendor relationships, CDW Corp. helps organizations navigate complex technology needs, including cloud adoption, cybersecurity, and modern workplace solutions.

Foghorn Therapeutics (FHTX) saw its shares jump 5.8% due to impressive trading volume and growing investor confidence linked to progress in its pipeline candidates for cancer treatments. The company is expected to report a quarterly loss of $0.23 per share and revenues of $8.12 million. Despite the recent surge, the consensus EPS estimate has remained unchanged, suggesting that sustained gains might depend on future earnings estimate revisions.

Gartner predicts that AI agents will impact enterprise software revenue models by $234 billion by 2030, diverting 20% of planned software spending to AI-driven alternatives. While this development poses a threat to traditional SaaS models, Gartner suggests it's a "metamorphosis" rather than an "apocalypse," with opportunities for vendors to embed agentic capabilities into their offerings. However, the proliferation of AI agents also raises concerns about data protection laws, as some agents running on frontier-level models have been found to consistently break regulations.

Electra Battery Materials Corporation (ELBM) is advancing its North American battery-materials platform by awarding a C$12.4 million construction package to Kilmarnock Enterprises for its cobalt sulfate refinery. This brings the total awarded construction packages to C$46 million, keeping the project on budget and schedule. The refinery is key to Electra's platform, which also includes developing black mass recycling for end-of-life lithium-ion batteries.

Brown Advisory's Large-Cap Growth Strategy sold off CoStar Group (CSGP) shares in Q1 2026 due to a declining near-term outlook, primarily driven by slower-than-expected ramp-up and increased investment in its residential platform, coupled with strategic uncertainties and a poor mortgage environment. The capital was reallocated to higher conviction opportunities. Despite CoStar Group's strong core business, the fund chose to divest, opting for other investments with greater promise, particularly in AI stocks.

Sysco Corp. is a leading global foodservice distributor, supplying a wide array of products to restaurants, healthcare facilities, and other institutions. The company leverages its extensive distribution network and diverse customer base, ranging from independent eateries to large chains, to maintain stable revenue streams. Sysco's performance is influenced by dining trends and cost pressures, which it manages through strategic pricing and operational efficiencies.

Fresenius Medical Care is updating its long-term dialysis strategy and care model to address the increasing global demand for chronic kidney treatment. The company, a major international player in renal therapy, aims to balance its role as a medical technology supplier with its extensive network of dialysis clinics. This integrated approach allows for the development and refinement of dialysis technologies directly within clinical practice, offering a range of treatment options to patients worldwide.

Taco Bell's Cheesy Gordita Crunch, a cult favorite, is a permanent menu item that anchors value-focused bundles across many US locations, contributing significantly to Yum! Brands Inc.'s traffic. The item's layered build and customizable proteins allow Taco Bell to maintain customer interest and perceived value, especially among younger, budget-conscious consumers. Its strategic role helps stabilize sales and drives loyalty program engagement within Yum! Brands' broader fast-food strategy.